Liddle’s Syndrome Caused by a Novel Mutation in the Proline-Rich PY Motif of the Epithelial Sodium Channel β-Subunit by Furuhashi, Masato, Kitamura, Kenichiro, Adachi, Masataka, Miyoshi, Taku, Wakida, Naoki, Ura, Nobuyuki, Shikano, Yasukuni, Shinshi, Yasuyuki, Sakamoto, Ken-ichi, Hayashi, Manabu, Satoh, Naotoshi, Nishitani, Takahiro, Tomita, Kimio, Shimamoto, Kazuaki

Get full text

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction ca... by Kato, Ken, Satoh, Taroh, Muro, Kei, Yoshikawa, Takaki, Tamura, Takao, Hamamoto, Yasuo, Chin, Keisho, Minashi, Keiko, Tsuda, Masahiro, Yamaguchi, Kensei, Machida, Nozomu, Esaki, Taito, Goto, Masahiro, Komatsu, Yoshito, Nakajima, Takako Eguchi, Sugimoto, Naotoshi, Yoshida, Kazuhiro, Oki, Eiji, Nishina, Tomohiro, Tsuji, Akihito, Fujii, Hirofumi, Kunieda, Kenji, Saitoh, Soh, Omuro, Yasushi, Azuma, Mizutomo, Iwamoto, Yasuo, Taku, Keisei, Fushida, Sachio, Chen, Li-Tzong, Kang, Yoon-Koo, Boku, Narikazu

Get full text

Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701 by Kawase, Tomono, Imamura, Hiroshi, Goto, Masahiro, Kimura, Yutaka, Ueda, Shugo, Matsuyama, Jin, Nishikawa, Kazuhiro, Sugimoto, Naotoshi, Fujita, Junya, Tamura, Takao, Fukushima, Norimasa, Kawakami, Hisato, Sakai, Daisuke, Kurokawa, Yukinori, Shimokawa, Toshio, Satoh, Taroh

Get full text

Comparison of S-1–cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve adv... by Kawakami, Hisato, Fujitani, Kazumasa, Matsuyama, Jin, Akamaru, Yusuke, Tamura, Shigeyuki, Endo, Shunji, Kimura, Yutaka, Makari, Youichi, Tamura, Takao, Sugimoto, Naotoshi, Sakai, Daisuke, Tsujinaka, Toshimasa, Goto, Masahiro, Kurokawa, Yukinori, Shimokawa, Toshio, Satoh, Taroh

Get full text

Short-term outcomes of a phase II trial of perioperative capecitabine plus oxaliplatin therapy for advanced gastric cancer with extensive lymph node metastases (OGSG1701) by Kimura, Yutaka, Sugimoto, Naotoshi, Endo, Shunji, Kawabata, Ryohei, Matsuyama, Jin, Takeno, Atsushi, Nakamura, Masato, Takeshita, Hiroki, Satake, Hironaga, Tamura, Shigeyuki, Sakai, Daisuke, Kawakami, Hisato, Kurokawa, Yukinori, Shimokawa, Toshio, Satoh, Taroh

Get full text

Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study) by Kotaka, Masahito, Iwamoto, Shigeyoshi, Satake, Hironaga, Sakai, Daisuke, Kudo, Toshihiro, Fukunaga, Mutsumi, Konishi, Ken, Ide, Yoshihito, Ikumoto, Taro, Tsuji, Akihito, Sano, Yasushi, Kato, Takeshi, Sugimoto, Naotoshi, Satoh, Taroh, Kanazawa, Akiyoshi, Kurata, Takayasu, Yamanaka, Takeharu, Tomita, Naohiro

Get full text

Phase II study of 5-fluorouracil–leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802) by Ohta, Takashi, Kato, Takeshi, Kawakami, Hisato, Miyake, Yasuhiro, Goto, Masahiro, Iwamoto, Shigeyoshi, Otsuji, Toshio, Nakamura, Masato, Sugimoto, Naotoshi, Okamura, Shu, Kotaka, Masahito, Tsujie, Masaki, Tokunaga, Yukihiko, Mishima, Hideyuki, Hata, Taishi, Shimokawa, Toshio, Kurokawa, Yukinori, Satoh, Taroh

Get full text

Randomized, Open‐Label Phase II Study Comparing Capecitabine‐Cisplatin Every 3 Weeks with S‐1‐Cisplatin Every 5 Weeks in Chemotherapy‐Naïve Patients with HER2‐Negative Advanced Gas... by Kawakami, Hisato, Takeno, Atsushi, Endo, Shunji, Makari, Yoichi, Kawada, Junji, Taniguchi, Hirokazu, Tamura, Shigeyuki, Sugimoto, Naotoshi, Kimura, Yutaka, Tamura, Takao, Fujitani, Kazumasa, Sakai, Daisuke, Shimokawa, Toshio, Kurokawa, Yukinori, Satoh, Taroh

Get full text

Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidin... by Sakai, Daisuke, Taniguchi, Hiroya, Sugimoto, Naotoshi, Tamura, Takao, Nishina, Tomohiro, Hara, Hiroki, Esaki, Taito, Denda, Tadamichi, Sakamoto, Takeshi, Okuda, Hiroyuki, Satoh, Taroh, Tsushima, Takahiro, Makiyama, Akitaka, Tsuda, Takashi, Hosokawa, Ayumu, Kuramochi, Hidekazu, Tokunaga, Shinya, Moriwaki, Toshikazu, Yasui, Hisateru, Ishida, Hiroyasu, Tsuji, Akihito, Otsu, Satoshi, Shimokawa, Hozumi, Baba, Eishi, Sato, Mikio, Matsumoto, Shigemi, Ozaki, Yukinori, Shinozaki, Katsunori, Tamagawa, Hiroshi, Goto, Masahiro, Kadowaki, Shigenori, Fujii, Hirofumi, Koh, Yasuhiro, Yamazaki, Kentaro, Hironaka, Shuichi, Kishimoto, Junji, Boku, Narikazu, Hyodo, Ichinosuke, Muro, Kei

Get full text

Efficacy of Pembrolizumab Monotherapy in Japanese Patients with Advanced Gastric or Gastroesophageal Junction Cancer by Muro, Kei, Shitara, Kohei, Yamaguchi, Kensei, Yoshikawa, Takaki, Satake, Hironaga, Hara, Hiroki, Sugimoto, Naotoshi, Machida, Nozomu, Goto, Masahiro, Kawakami, Hisato, Amagai, Kenji, Omuro, Yasushi, Esaki, Taito, Hironaka, Shuichi, Nishina, Tomohiro, Komatsu, Yoshito, Matsubara, Hisahiro, Shiratori, Shinichi, Han, Shirong, Satoh, Taroh, Ohtsu, Atsushi

Get full text

Existence of phenol oxidase in the argasid tick Ornithodoros moubata by KADOTA, Kimie, SATOH, Eiki, OCHIAI, Masanari, INOUE, Noboru, TSUJI, Naotoshi, IGARASHI, Ikuo, NAGASAWA, Hideyuki, MIKAMI, Takeshi, CLAVERIA, Florencia G, FUJISAKI, Kozo

Get full text